Triple-negative breast cancer (TNBC) is a heterogeneous group of cancers defined by lack of expression of estrogen receptor (Er), progesterone receptor (Pr) and human epidermal growth factor receptor2 (Her2) [1,2]. This evidence concerns the gene PGR and triple-negative breast carcinoma.